{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:04:28Z","timestamp":1794355468991,"version":"4.9.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["CHEMIE.PGT.2019.002"],"award-info":[{"award-number":["CHEMIE.PGT.2019.002"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221712\/Z\/20\/Z"],"award-info":[{"award-number":["221712\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221710\/Z\/20\/Z"],"award-info":[{"award-number":["221710\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon: X"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.toxcx.2024.100185","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T13:00:02Z","timestamp":1708088402000},"page":"100185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite"],"prefix":"10.1016","volume":"21","author":[{"given":"Julien","family":"Slagboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail H.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietse M.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rien","family":"van Haperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ty\u00e1s A.","family":"Bittenbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek J.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Grosveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravka","family":"Drabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-018-0039-1","article-title":"The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms","volume":"1","author":"Ainsworth","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.toxcx.2024.100185_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphar.2019.00848","article-title":"A decoy-receptor approach using nicotinic acetylcholine receptor mimics reveals their potential as novel therapeutics against neurotoxic snakebite","author":"Albulescu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib3","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/s41467-020-19981-6","article-title":"A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.toxcx.2024.100185_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/toxins14070469","article-title":"Exploring the utility of ssDNA aptamers directed against snake venom toxins as new therapeutics for snakebite envenoming","volume":"14","author":"Alomran","year":"2022","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.toxcx.2024.100185_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00005-014-0322-x","article-title":"Human antibody production in transgenic animals","volume":"63","author":"Br\u00fcggemann","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"5","key":"10.1016\/j.toxcx.2024.100185_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.toxcx.2024.100185_bib7","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jms.1242","article-title":"Snake venomics. Strategy and applications","volume":"42","author":"Calvete","year":"2007","journal-title":"J. Mass Spectrom."},{"issue":"11","key":"10.1016\/j.toxcx.2024.100185_bib8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.febslet.2009.03.029","article-title":"Venoms, venomics, antivenomics","volume":"583","author":"Calvete","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxcx.2024.100185_bib9","article-title":"Strategies for generating diverse antibody repertoires using transgenic animals expressing human antibodies","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.toxcx.2024.100185_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2021.02.005","article-title":"Small molecule drug discovery for neglected tropical snakebite","volume":"42","author":"Clare","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.toxcx.2024.100185_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.toxcx.2024.100185_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.1637","article-title":"The pharmacological role of nucleotidases in snake venoms","volume":"28","author":"Dhananjaya","year":"2010","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.toxcx.2024.100185_bib13","first-page":"171","article-title":"Snake venom nucleases, nucleotidases, and phosphomonoesterases","volume":"155","author":"Dhananjaya","year":"2010","journal-title":"Handbook of venoms and toxins of reptiles"},{"issue":"9","key":"10.1016\/j.toxcx.2024.100185_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/toxins14090606","article-title":"Antibodies as snakebite antivenoms: past and future","volume":"14","author":"Dias da Silva","year":"2022","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.toxcx.2024.100185_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.febslet.2013.11.025","article-title":"Therapeutic antibody engineering by high efficiency cell screening","volume":"588","author":"Doerner","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxcx.2024.100185_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2016.00619","article-title":"Expression cloning and production of human heavy-chain-only antibodies from murine transgenic plasma cells","volume":"7","author":"Drabek","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxcx.2024.100185_bib17","series-title":"Single-Domain Antibodies: Methods and Protocols","first-page":"121","article-title":"A transgenic heavy chain IgG mouse platform as a source of high affinity fully human single-domain antibodies for therapeutic applications","author":"Drabek","year":"2022"},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0041-0101(02)00102-2","article-title":"Snake venom L-amino acid oxidases","volume":"40","author":"Du","year":"2002","journal-title":"Toxicon"},{"issue":"73","key":"10.1016\/j.toxcx.2024.100185_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp9312","article-title":"An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern","volume":"7","author":"Du","year":"2022","journal-title":"Sci. Immunol."},{"issue":"7","key":"10.1016\/j.toxcx.2024.100185_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001492","article-title":"Dramatic and concerted conformational changes enable rhodocetin to block \u03b12\u03b21 integrin selectively","volume":"15","author":"Eble","year":"2017","journal-title":"PLoS Biol."},{"issue":"32","key":"10.1016\/j.toxcx.2024.100185_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200879119","article-title":"An anti-CTLA-4 heavy chain\u2013only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile","volume":"119","author":"Gan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/15701638113109990038","article-title":"Transgenic mouse strains as platforms for the successful discovery and development of human therapeutic monoclonal antibodies","volume":"11","author":"Green","year":"2014","journal-title":"Curr. Drug Discov. Technol."},{"issue":"3","key":"10.1016\/j.toxcx.2024.100185_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.toxicon.2012.05.001","article-title":"Past decade study of snake venom L-amino acid oxidase","volume":"60","author":"Guo","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.toxcx.2024.100185_bib24","first-page":"1","article-title":"Immobilized enzyme for screening and identification of anti-diabetic components from natural products by ligand fishing","author":"Guo","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib25","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"34","key":"10.1016\/j.toxcx.2024.100185_bib26","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","article-title":"From fangs to pharmacology: the future of snakebite envenoming therapy","volume":"22","author":"H Laustsen","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2","key":"10.1016\/j.toxcx.2024.100185_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cbpc.2010.10.007","article-title":"Intraspecies variability in Vipera ammodytes ammodytes venom related to its toxicity and immunogenic potential","volume":"153","author":"Halassy","year":"2011","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"issue":"12","key":"10.1016\/j.toxcx.2024.100185_bib28","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"9","key":"10.1016\/j.toxcx.2024.100185_bib29","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jprot.2011.06.019","article-title":"Research strategies to improve snakebite treatment: challenges and progress","volume":"74","author":"Harrison","year":"2011","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.toxcx.2024.100185_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/196754","article-title":"Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry","volume":"2014","author":"Izidoro","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0969-2126(01)00136-8","article-title":"Model for the complex between protein G and an antibody Fc fragment in solution","volume":"3","author":"Kato","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.toxcx.2024.100185_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jprot.2016.02.003","article-title":"Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)","volume":"136","author":"Lauridsen","year":"2016","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.toxcx.2024.100185_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2018","journal-title":"N. Biotech."},{"key":"10.1016\/j.toxcx.2024.100185_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib35","first-page":"1","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.toxcx.2024.100185_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins12050309","article-title":"Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the western diamondback rattlesnake","volume":"12","author":"Layfield","year":"2020","journal-title":"Crotalus atrox. Toxins."},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201900247","article-title":"Assuring clonality on the beacon digital cell line development platform","volume":"15","author":"Le","year":"2020","journal-title":"Biotechnol. J."},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib40","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/pr8000139","article-title":"Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii","volume":"7","author":"Lomonte","year":"2008","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib42","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1046\/j.1432-1327.2001.02042.x","article-title":"L-Amino-acid oxidase from the Malayan pit viper Calloselasma rhodostoma","volume":"268","author":"Macheroux","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"14","key":"10.1016\/j.toxcx.2024.100185_bib43","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1021\/ac070268+","article-title":"Automated ligand fishing using human serum albumin-coated magnetic beads","volume":"79","author":"Moaddel","year":"2007","journal-title":"Anal. Chem."},{"issue":"24","key":"10.1016\/j.toxcx.2024.100185_bib44","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1074\/jbc.M101585200","volume":"276","author":"Navdaev","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.toxcx.2024.100185_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0041-0101(83)90127-7","article-title":"Inhibition of platelet aggregation by 5\u2032-nucleotidase purified from Trimeresurus gramineus snake venom","volume":"21","author":"Ouyang","year":"1983","journal-title":"Toxicon"},{"issue":"18","key":"10.1016\/j.toxcx.2024.100185_bib46","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability\u2010based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis: Int. J."},{"issue":"10","key":"10.1016\/j.toxcx.2024.100185_bib47","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/j.1742-4658.2005.04687.x","article-title":"A strategy for the generation of specific human antibodies by directed evolution and phage display: an example of a single\u2010chain antibody fragment that neutralizes a major component of scorpion venom","volume":"272","author":"Riano\u2010Umbarila","year":"2005","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.14591","article-title":"Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise","volume":"177","author":"Slagboom","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.toxcx.2024.100185_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107187","article-title":"Analytical strategies in venomics","author":"Slagboom","year":"2022","journal-title":"Microchem. J."},{"issue":"6","key":"10.1016\/j.toxcx.2024.100185_bib50","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1021\/acs.jproteome.2c00780","article-title":"High-throughput venomics","volume":"22","author":"Slagboom","year":"2023","journal-title":"J. Proteome Res. 2023"},{"key":"10.1016\/j.toxcx.2024.100185_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxicon.2019.08.004","article-title":"Comparative proteomes, immunoreactivities and neutralization of procoagulant activities of Calloselasma rhodostoma (Malayan pit viper) venoms from four regions in Southeast Asia","volume":"169","author":"Tang","year":"2019","journal-title":"Toxicon"},{"issue":"22","key":"10.1016\/j.toxcx.2024.100185_bib52","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1046\/j.1432-1327.2000.01766.x","article-title":"Phospholipases A2 from Callosellasma rhodostoma venom gland: cloning and sequencing of 10 of the cDNAs, three\u2010dimensional modelling and chemical modification of the major isozyme","volume":"267","author":"Tsai","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"23","key":"10.1016\/j.toxcx.2024.100185_bib53","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1021\/bi982132z","article-title":"Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (malayan pit viper): synergistic and noncovalent interaction between its subunits","volume":"38","author":"Wang","year":"1999","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.toxcx.2024.100185_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-022-00100-4","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"3","author":"Wang","year":"2022","journal-title":"Molecular Biomed."},{"issue":"9708","key":"10.1016\/j.toxcx.2024.100185_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","article-title":"Snake bite","volume":"375","author":"Warrell","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.toxcx.2024.100185_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"issue":"11","key":"10.1016\/j.toxcx.2024.100185_bib57","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/molecules21111516","article-title":"Ligand fishing: a remarkable strategy for discovering bioactive compounds from complex mixture of natural products","volume":"21","author":"Zhuo","year":"2016","journal-title":"Molecules"}],"container-title":["Toxicon: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259017102400002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259017102400002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:14:07Z","timestamp":1778912047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259017102400002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":57,"alternative-id":["S259017102400002X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxcx.2024.100185","relation":{},"ISSN":["2590-1710"],"issn-type":[{"value":"2590-1710","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite","name":"articletitle","label":"Article Title"},{"value":"Toxicon: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxcx.2024.100185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100185"}}